105 related articles for article (PubMed ID: 10940700)
1. A new prostatic stent for the treatment of benign prostatic hyperplasia in high-risk patients.
Traxer O; Anidjar M; Gaudez F; Saporta F; Daudon M; Cortesse A; Desgrandchamps F; Cussenot O; Teillac P; Le Duc A
Eur Urol; 2000 Sep; 38(3):272-8. PubMed ID: 10940700
[TBL] [Abstract][Full Text] [Related]
2. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
3. [Mesh-like tubular stent treatment for chronic urinary retention caused by benign prostatic hypertrophy].
Wang X; Zhu J; Hou S
Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):107-9. PubMed ID: 9388336
[TBL] [Abstract][Full Text] [Related]
4. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
Laaksovirta S; Isotalo T; Talja M; Välimaa T; Törmälä P; Tammela TL
J Endourol; 2002 Jun; 16(5):311-5. PubMed ID: 12184083
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
6. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
8. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
9. Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.
Laaksovirta S; Talja M; Välimaa T; Isotalo T; Törmälä P; Tammela TL
J Urol; 2001 Sep; 166(3):919-22. PubMed ID: 11490246
[TBL] [Abstract][Full Text] [Related]
10. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
Fuse H; Okumura A; Sakamoto M; Katayama T
Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
[TBL] [Abstract][Full Text] [Related]
11. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
12. A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate.
Pétas A; Isotalo T; Talja M; Tammela TL; Välimaa T; Törmälä P
Scand J Urol Nephrol; 2000 Aug; 34(4):262-6. PubMed ID: 11095085
[TBL] [Abstract][Full Text] [Related]
13. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
14. [Outcome analysis of the urethral stent (Memotherm®)].
Sakamoto H; Matsuda A; Arakaki R; Yamada H
Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of the Porges Urospiral, a reversible intraprostatic spiral stent, in patients with benign prostatic hypertrophy].
Uchida J; Kawamura H; Fujita I; Oguchi N; Matsuda T; Ashida M; Kikkawa A; Doi T; Amazutsumi K; Ohara T
Hinyokika Kiyo; 1995 Apr; 41(4):323-8. PubMed ID: 7540360
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
17. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
18. Allium™ TPS--A New Prostatic Stent for the Treatment of Patients with Benign Prostatic Obstruction: The First Report.
Yildiz G; Bahouth Z; Halachmi S; Meyer G; Nativ O; Moskovitz B
J Endourol; 2016 Mar; 30(3):319-22. PubMed ID: 26472166
[TBL] [Abstract][Full Text] [Related]
19. Thermosensitive stent (Memotherm) for the treatment of benign prostatic hyperplasia.
Gottfried HW; Schlmers HP; Gschwend J; Brändle E; Hautmann RE
Arch Esp Urol; 1994 Nov; 47(9):933-43; discussion 943-6. PubMed ID: 7530951
[TBL] [Abstract][Full Text] [Related]
20. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine.
Kehinde EO; Abul F
Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
